Peoples Bank OH Sells 163 Shares of Stryker Co. (NYSE:SYK)

Peoples Bank OH decreased its holdings in shares of Stryker Co. (NYSE:SYK) by 12.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,105 shares of the medical technology company’s stock after selling 163 shares during the period. Peoples Bank OH’s holdings in Stryker were worth $398,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in SYK. Foundations Investment Advisors LLC increased its position in shares of Stryker by 10.0% in the 3rd quarter. Foundations Investment Advisors LLC now owns 1,753 shares of the medical technology company’s stock valued at $633,000 after buying an additional 160 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in shares of Stryker by 1.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 11,236 shares of the medical technology company’s stock valued at $4,059,000 after buying an additional 187 shares in the last quarter. Stanley Laman Group Ltd. increased its position in shares of Stryker by 83.4% in the 3rd quarter. Stanley Laman Group Ltd. now owns 1,379 shares of the medical technology company’s stock valued at $498,000 after buying an additional 627 shares in the last quarter. Private Advisor Group LLC increased its position in shares of Stryker by 3.4% in the 3rd quarter. Private Advisor Group LLC now owns 15,967 shares of the medical technology company’s stock valued at $5,768,000 after buying an additional 526 shares in the last quarter. Finally, Commerzbank Aktiengesellschaft FI increased its position in shares of Stryker by 141.4% in the 3rd quarter. Commerzbank Aktiengesellschaft FI now owns 3,577 shares of the medical technology company’s stock valued at $1,292,000 after buying an additional 2,095 shares in the last quarter. Institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 201,392 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the transaction, the director now directly owns 14,895 shares in the company, valued at $5,705,827.65. This represents a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on SYK. Needham & Company LLC reaffirmed a “buy” rating and issued a $442.00 target price on shares of Stryker in a research note on Wednesday, January 29th. StockNews.com lowered shares of Stryker from a “buy” rating to a “hold” rating in a research note on Thursday, January 30th. JMP Securities reaffirmed a “market perform” rating on shares of Stryker in a research note on Tuesday. BTIG Research upped their target price on shares of Stryker from $383.00 to $394.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Finally, Royal Bank of Canada upped their target price on shares of Stryker from $425.00 to $435.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and an average target price of $420.68.

Stryker Stock Down 0.5 %

Shares of SYK stock opened at $386.47 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The firm’s 50-day moving average is $377.92 and its 200-day moving average is $368.21. The stock has a market cap of $147.47 billion, a price-to-earnings ratio of 49.80, a PEG ratio of 2.93 and a beta of 0.96. Stryker Co. has a 52-week low of $314.93 and a 52-week high of $406.19.

Stryker (NYSE:SYK) last issued its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period in the previous year, the business posted $3.46 EPS. Sell-side analysts predict that Stryker Co. will post 13.49 EPS for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be issued a $0.84 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.87%. Stryker’s payout ratio is 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.